Similar Papers

Paper Title
Journal
Date
Author
Gefitinib (G) versus vinorelbine+cisplatin (VP) as adjuvant treatment in stage II-IIIA (N1-N2) non-small-cell lung cancer (NSCLC) with EGFR-activating mutation (ADJUVANT): A randomized, Phase III trial (CTONG 1104).
...
Journal of Clinical Oncology | VOL. 35
, et. al. ...
20 May 2017
Cost-effectiveness analysis of adjuvant atezolizumab in stage II-IIIA non-small cell lung cancer expressing ≥50% PD-L1: A United Kingdom health care perspective
Chui-Ying Yip ... Nick Jovanoski
Lung Cancer | VOL. 179
Chui-Ying Yip, et. al.Chui-Ying Yip ... Nick Jovanoski
15 Mar 2023
Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer
Chi-Fu Jeffrey Yang ... Jacob A Klapper
The Annals of Thoracic Surgery | VOL. 105
Chi-Fu Jeffrey Yang, et. al.Chi-Fu Jeffrey Yang ... Jacob A Klapper
16 Dec 2017
Cost-effectiveness analysis of atezolizumab as adjuvant treatment of patients with stage II-IIIA non-small cell lung cancer, PD-L1+≥50% of tumor cells in France: A modeling study
Ingrid Plessala ... Christos Chouaid
Lung Cancer | VOL. 184
Ingrid Plessala, et. al.Ingrid Plessala ... Christos Chouaid
26 Jul 2023
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
HIV Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in Non-Small Cell Lung Cancer
Baptiste Abbar ... Brigitte Autran
Journal of Thoracic Oncology | VOL. -
Baptiste Abbar, et. al.Baptiste Abbar ... Brigitte Autran
01 Feb 2025
Meeting Announcements
-
Journal of Thoracic Oncology | VOL. 20
--
01 Feb 2025
Safety, Pharmacokinetics, and Efficacy of TY-9591 (Deuterated Osimertinib Derivative) in Advanced EGFR-mutated Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation and Dose-Expansion Study
Baohui Han ... Yusheng Wu
Journal of Thoracic Oncology | VOL. -
Baohui Han, et. al.Baohui Han ... Yusheng Wu
01 Feb 2025
First-Line Camrelizumab versus Placebo Plus Chemotherapy with or without Radiotherapy for Brain Metastases in Non-Small-Cell Lung Cancer: The CTONG 2003 Randomized Placebo-Controlled Trial
Yang-Si Li ... Yi-Long Wu
Journal of Thoracic Oncology | VOL. -
Yang-Si Li, et. al.Yang-Si Li ... Yi-Long Wu
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.